Prof. Alain Cribier

Alain Cribier

Interventional cardiologist / Cardiologist
Hôpital Charles Nicolle - Rouen, France

After introducing balloon dilatation of centric aortic valves, he conceived and developed TAVI, the transcatheter delivery of an aortic bioprosthesis anchored in situ via a stented frame. This procedure was proven to be life-saving in inoperable patients and can now be offered to patients with high or moderate surgical risk.

Latest contributions

First FIM Percutaneously Implanted Heart Valve (PHV) implantation on 16 April, 2002

On April 16, 2002, at the Charles Nicolle University Hospital in Rouen, France, the Interventional Cardiologist, Professor Alain Cribier performed the first transcatheter aortic valve replacement procedure in the world. He used a Prosthetic valve thrombosis (PVT) percutaneous heart valve.

Prof. Alain Cribier

Author

Alain Cribier

Commemorating the 15-year anniversary of TAVI: insights into the early stages of development, from concept to human application, and perspectives

A. Cribier. shares his experience of cardiac catheterisation in the early 1970s and follow the fascinating evolution of the technology over the past 40 years.

Authors :

Alain Cribier

Moderated posters - session 4

18 May 2017 – From EuroPCR 2017

TAVI in bicuspid valves

17 May 2017 – From EuroPCR 2017

TAVI registries and durability

16 May 2017 – From EuroPCR 2017

TAVI complications - part 2

20 May 2016 – From EuroPCR 2016

Consult the video on TAVI complications - part 2, session comprising of selected EuroPCR 2016 clinical case submissions.

Prof. Alain Cribier

Chairperson

Alain Cribier

LIVE demonstration: Making TAVI simple in lower-risk patients

19 Sep 2016 – From PCR London Valves 2016

Darren Mylotte

Chairperson

Darren Mylotte
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Moving TAVI to lower-risk populations

19 Sep 2016 – From PCR London Valves 2016

Darren Mylotte

Chairperson

Darren Mylotte
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Extending the indications for TAVI to patients with asymptomatic severe aortic stenosis

20 Sep 2016 – From PCR London Valves 2016

Dr. Martin B. Leon

Chairperson

Martin B. Leon

Chairperson

Philippe Pibarot

TAVI complications

19 Sep 2016 – From PCR London Valves 2016

Difficult and alternative access

19 May 2016 – From EuroPCR 2016

How to avoid and solve technical difficulties?

19 May 2016 – From EuroPCR 2016

Prof. Alain Cribier

Chairperson

Alain Cribier
Hélène Eltchaninoff

Chairperson

Hélène Eltchaninoff

Balloon aortic valvuloplasty as a forgotten therapy

17 May 2016 – From EuroPCR 2016

Prof. Alain Cribier

Chairperson

Alain Cribier

TAVI registries

17 May 2016 – From EuroPCR 2016

TAVI: challenging cases

22 Sep 2015 – From PCR London Valves 2015

Prof. Alain Cribier

Chairperson

Alain Cribier

The impact of mitral valve disease in the TAVI patient

22 Sep 2015 – From PCR London Valves 2015

Watch this session if you want to understand the importance of mitral valve disease in the setting of severe aortic stenosis, gain insights as to whether mitral regurgitation will improve after TAVI and learn more about the indications for combined percutaneous valve interventions.

Prof. Jeroen J. Bax

Chairperson

Jeroen Bax
Dr Bernard Prendergast

Chairperson

Bernard Prendergast

Valve interventions under conscious sedation

21 Sep 2015 – From PCR London Valves 2015

Karl-Heinz Kuck

Chairperson

Karl-Heinz Kuck
Thierry Lefèvre

Chairperson

Thierry Lefèvre

A future vision of TAVI - A simplified and reproducible procedure

22 May 2015 – From EuroPCR 2015

Corrado Tamburino

Chairperson

Corrado Tamburino

Is paravalvar aortic regurgitation a problem of the past?

21 May 2015 – From EuroPCR 2015

Watch this session video from EuroPCR 2015 weather paravalvar aortic regurgitation is a problem of the past?

Hot line - Trial updates, registries and practice in structural heart disease

21 May 2015 – From EuroPCR 2015

Prof. Alain Cribier

Chairperson

Alain Cribier

TAVI in intermediate-risk patients - What should we be doing now?

20 May 2015 – From EuroPCR 2015

Consult this session video from EuroPCR 2015 on TAVI in intermediate-risk patients: what should we be doing now?

Michael Haude

Chairperson

Michael Haude

TAVI in low gradient aortic stenosis with very poor left ventricular function: always, sometimes or never?

22 May 2014 – From EuroPCR 2014

Prof. Alain Cribier

Chairperson

Alain Cribier
Dr. Martin B. Leon

Chairperson

Martin B. Leon

Paravalvular aortic regurgitation after TAVI - The most important remaining limitation

21 May 2014 – From EuroPCR 2014

Philip MacCarthy

Chairperson

Philip MacCarthy
Prof. Thomas Walther

Chairperson

Thomas Walther

Left ventricular function in TAVI

20 May 2014 – From EuroPCR 2014

Prof. Alain Cribier

Chairperson

Alain Cribier

Chairperson

Gry Dahle

The transapical approach: is there a current and future role?

17 Sep 2013 – From PCR London Valves 2013

Karl-Heinz Kuck

Chairperson

Karl-Heinz Kuck
Prof. Olaf Wendler

Chairperson

Olaf Wendler

What is the known unknown about TAVI?

16 Sep 2013 – From PCR London Valves 2013

Prof. Alain Cribier

Chairperson

Alain Cribier

Chairperson

Neil Moat

How to deploy the St Jude Medical Portico TAVI device and the Direct Flow Medical TAVI device

16 Sep 2013 – From PCR London Valves 2013

Chairperson

Josep Rodes Cabau
Prof. Thomas Walther

Chairperson

Thomas Walther

TAVI and bleeding complication

23 May 2013 – From EuroPCR 2013

Prof. Alain Cribier

Chairperson

Alain Cribier
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Incidence and prevention of cerebrovascular events after TAVI

23 May 2013 – From EuroPCR 2013

TAVI results from worldwide registries

21 May 2013 – From EuroPCR 2013

Prof. Alain Cribier

Chairperson

Alain Cribier
Prof. Junbo Ge

Chairperson

Junbo Ge